Tag:Pyrilutamide Phase 2 Trial Androgenic Alopecia
Updated on September 8, 2021
Kintor’s KX-826 Pyrilutamide Meets Goal In Phase 2 Trial
Kintor Pharmaceutical of China brings us some timely good news today regarding its lead candidate drug KX-826 for the treatment of androgenetic alopecia. Phase 3 Will Be Soon A well respected company in the hair growth industry, Kintor …